Eupalinolide A(b)

CAS No. 877822-40-7

Eupalinolide A(b)( —— )

Catalog No. M20698 CAS No. 877822-40-7

Eupalinolide B is a natural product and demonstrates potent cytotoxicity against A-549 BGC-823 SMMC-7721 and HL-60 tumour cell lines.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 59 Get Quote
10MG 95 Get Quote
25MG 200 Get Quote
50MG 295 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Eupalinolide A(b)
  • Note
    Research use only, not for human use.
  • Brief Description
    Eupalinolide B is a natural product and demonstrates potent cytotoxicity against A-549 BGC-823 SMMC-7721 and HL-60 tumour cell lines.
  • Description
    Eupalinolide B is a natural product and demonstrates potent cytotoxicity against A-549 BGC-823 SMMC-7721 and HL-60 tumour cell lines.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cytoskeleton/Cell Adhesion Molecules
  • Target
    HSP
  • Recptor
    HSP90
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    877822-40-7
  • Formula Weight
    462.49
  • Molecular Formula
    C24H30O9
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (216.22 mM)
  • SMILES
    CC(=O)OC\C1=C/C[C@H](OC(C)=O)\C(C)=C\[C@H]2OC(=O)C(=C)[C@@H]2[C@@H](C1)OC(=O)C(\C)=C\CO
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Yamashita Y Ikeda T Matsuda M et al. Purification and characterization of HSP-inducers from Eupatorium lindleyanum[J]. Biochemical Pharmacology 2012 83(7):909-922.
molnova catalog
related products
  • SNX 2112

    SNX 2112 (PF 04928473) is a potent, selective Hsp90 inhibitor with binding IC50 of 30 nM for both HSP90α and HSP90β.

  • HSF1A

    A small molecule human HSF1 (heat shock transcription factor 1) activator.

  • NPX800

    NPX800 is an inhibitor of heat shock factor 1 (HSF1) and can be used in studies about the treatment of cancer.